SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,140.90 -401.54
( -0.51%)

Global Indices

Nasdaq

53,996.18 -61.75
(-0.11%)

Dow Jones

7,774.29 -4.35
(-0.06%)

Hang Seng

66,870.65 1,263.94
(1.93%)

Nikkei 225

10,869.98 -31.11
(-0.29%)

Forex

USD-INR

95.15 -0.05
(-0.05%)

EUR-INR

109.97 0.14
(0.13%)

GBP-INR

128.34 0.21
(0.16%)

JPY-INR

0.60 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.81

983.67

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.06

Back

angel one ltd

UltraTech Cement consolidated net profit rises 16.77% in the June 2026 quarter

Jul 20,2026

Net profit of UltraTech Cement rose 16.77% to Rs 2599.28 crore in the quarter ended June 2026 as against Rs 2225.90 crore during the previous quarter ended June 2025. Sales rose 15.85% to Rs 24648.20 crore in the quarter ended June 2026 as against Rs 21275.45 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	24648.20	21275.45	16
OPM %	20.35	20.71	-
PBDT	4694.19	4152.96	13
PBT	3493.68	3046.18	15
NP	2599.28	2225.90	17

78,140.90 -401.54 ( -0.51%)

53,996.18 -61.75 (-0.11%)

7,774.29 -4.35 (-0.06%)

66,870.65 1,263.94 (1.93%)

10,869.98 -31.11 (-0.29%)

95.15 -0.05 (-0.05%)

109.97 0.14 (0.13%)

128.34 0.21 (0.16%)

0.60 0.00 (0.09%)